Mumbai: After completing two admission cycles, several city colleges that shifted to the All-India Council for Technical ...

Over the last two years, several IIMs have expanded beyond their flagship MBA programmes by launching undergraduate courses, ...

Pfizer could soon launch a multi-billion dollar bid for immunotherapy rivals Bristol-Myers Squibb. But moves into new fields of innovation and digital tech – such as Roche’s buyout of Flatiron - are ...

Across 3,600 miles of highway, a Rivian R1T owner proved that while charging is no longer the "Achilles' heel" of EV travel, ...

Well, here we are. It’s the final countdown. Whether you’re ringing in the new year with chosen family, your partner, a first ...

These deals radically reshaped the biopharma world, either by one vaccine rival absorbing another, a Big Pharma doubling down after another failed acquisition or, in the case of Pfizer and Novo, two ...

With an EV, you're unlikely to achieve the stated mileage unless you adjust your driving habits and learn the subtleties of ...

It’s been another whirlwind year in the world of pharma marketing. | Updates on DTC advertising and DTP programs, as well as special reports, event coverage and, of course, news bulletins from the ...

Every winter, Bristol Motor Speedway transforms from a major sports and entertainment destination into a glowing holiday ...

For H1 2025 Lloyd’s posted a £4.2bn ($5.6bn) H1 profit before tax which Tiernan called a “solid half-year performance, demonstrating strength and resilience”. This was down £700mn year on year, as ...

From an investment perspective, Propanc offers a striking contrast to the high-valuation tech stocks now under rotation pressure. With a market capitalization under $15 million, it trades at a ...

President Trump announced nine more companies joining TrumpRx, aiming for U.S.-Europe drug price parity using tariffs as leverage. TrumpRx will offer future drug releases at most-favored-nation ...